Martin, Sophie <br/><br/>
Delphinidin inhibits endothelial cell proliferation and cell cycle progression through a transient activation of ERK-1/-2.  [electronic resource] 

 -  Biochemical pharmacology  Feb 2003 
 - 669-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-2952 
<br/><br/><label>Standard No.: </label>10.1016/s0006-2952(02)01568-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthocyanins--pharmacology<br/>Cattle<br/>Caveolin 1<br/>Caveolins--metabolism<br/>Cell Cycle--drug effects<br/>Cell Division--drug effects<br/>Cyclin D1--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p21<br/>Cyclins--metabolism<br/>Down-Regulation--drug effects<br/>Endothelial Growth Factors--pharmacology<br/>Endothelium, Vascular--cytology<br/>Enzyme Activation--drug effects<br/>G1 Phase--drug effects<br/>Gene Expression Regulation--drug effects<br/>Immune Sera--pharmacology<br/>Intercellular Signaling Peptides and Proteins--pharmacology<br/>Lymphokines--pharmacology<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Nitric Oxide--metabolism<br/>S Phase--drug effects<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factors<br/>ras Proteins--metabolism